CRANBURY, N.J.--(BUSINESS WIRE)--Pharmacy Times Continuing Education™ (PTCE), a leader in continuing education for retail, health-system, managed care and specialty pharmacists, will host two continuing education (CE) symposia in conjunction with the Hematology/ Oncology Pharmacy Association (HOPA) 14TH Annual Conference this month.
“We are thrilled to offer these symposia for oncology pharmacists,” said David Heckard, PTCE president. “There has been significant advancement in treatment of prostate cancer and management of chemotherapy induced nausea and vomiting, which is experienced by almost all patients undergoing chemotherapy. We look forward to discussing these advancements and highlighting the pharmacological role in tackling the arising issues.”
The PTCE symposia are as follows:
The Role of the Clinical Pharmacist in Reducing the Clinical Impact
of Prostate Cancer: New and Emerging Therapy Options, will take
place on March 22 at the Mile High Ballroom 3 in Colorado Convention
Center in Denver, Colorado at 7:30 p.m. (MT). The symposium will
feature Lisa M. Holle, Pharm.D, BCOP, FHOPA, associate clinical
professor, University of Connecticut (UConn) School of Pharmacy,
department of pharmacy practice, and associate professor, UConn School
of Medicine, Storrs; and Guru Sonpavde, M.D., bladder cancer
director, Dana-Farber Cancer Institute, Boston, Massachusetts, as
For more information and to register, visit https://www.pharmacytimes.org/prostate18.
New Options in the Management of Chemotherapy-Induced Nausea and
Vomiting, will be held on March 23 at the Mile High Ballroom 2,
Colorado Convention Center at 6 a.m. (MT). The program will be hosted
by Richard J. Gralla, M.D., FACP, professor of medicine, Albert
Einstein College of Medicine, Bronx, New York, and Scott Soefje,
Pharm.D, MBA, BCOP, FCCP, director, pharmacy cancer care service,
Mayo Clinic, Rochester, Minnesota.
For more information and to register, visit https://www.pharmacytimes.org/cinv18.
Both symposia will delve further into the role of clinical pharmacists and pharmacologic management in oncology. Each activity will identify ongoing problems faced by cancer patients and share insight on ways pharmacists can provide guidance and individualized patient care. Each symposium is accredited by the Accreditation Council for Pharmacy Education (ACPE) and is approved for 1.5 contact hours.
About Pharmacy Times Continuing Education™
Pharmacy Times Continuing Education™ (PTCE) is a leader in continuing education for retail, health-system, managed care and specialty pharmacists. PTCE™ is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (CPE). Our print, online and live CPE activities are designed to help improve the knowledge, competence and skills of pharmacists so they are better prepared to provide the highest quality of pharmacy care to the patients they serve and to the physicians they assist as part of a multidisciplinary treatment/management team. To learn more about the educational activities sponsored by PTCE, visit our website at https://www.pharmacytimes.org/.